ArticleBlood advances2022
Abramson JS, Siddiqi T, Garcia J, et al. Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel-treated patients in the TRANSCEND NHL 001 trial. Blood Adv. 2021;5(6):1695-1705.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.